新辅助经肝动脉化疗栓塞术提高肝细胞癌患者

Objectives:OuraimsweretodeterminewhethertransarterialchemoembolizationbeforelivertransplantforhepatocellularcarcinomaimprovesposttransplantsurvivalandwhetherpatientsdownstagedbytransarterialchemoembolizationwithinMilancriteriahaveaposttransplantsurvivalbenefit.

目的：探讨肝细胞癌患者肝移植前行经动脉化疗栓塞（TACE）能否提高肝移植后的生存，以及TACE治疗后肿瘤分期降低至米兰标准的患者在移植术后的生存是否获益。

MaterialsandMethods:Inthisretrospectiveanalysisofprospectivelycollecteddata,survivalratesof87patientstreatedwithand68patientsnottreatedwithtransarterialchemoembolizationbeforelivertransplantwere

转载请注明：http://www.qhanqh.com/gsjzl/4561.html